Latest

BMJ

·June 25, 2025·4 min read

Autoimmune Disease Doubles Risk of Depression and Anxiety

People living with autoimmune diseases face nearly twice the risk of developing persistent mental health disorders like depression, anxiety, and bipolar disorder, according to a massive UK-based study. Researchers suggest chronic inflammation may play a key role in this connection, especially in women who showed significantly higher risk levels than men.

Featured Neuroscience Psychology

·June 4, 2025·5 min read

Low-Calorie Diets May Increase Depression Risk

New research links low-calorie diets with a slight increase in depressive symptoms, particularly among overweight individuals and men. The large observational study analyzed dietary habits and depression scores in over 28,000 U.S. adults.

Featured Neurology Neuroscience

·May 21, 2025·4 min read

Cold Sore Virus Linked to Alzheimer’s, Antivirals May Lower Risk

A large study suggests that symptomatic infection with herpes simplex virus 1 (HSV-1)—best known for causing cold sores—may significantly raise the risk of developing Alzheimer’s disease. Researchers found that people with HSV-1 were 80% more likely to have Alzheimer’s, while those treated with antiviral medications had a 17% lower risk.

Featured Neurology Neuroscience

·September 25, 2024·3 min read

Alzheimer’s Drug Faces Scrutiny Over Safety, Efficacy Concerns

The FDA-approved Alzheimer’s drug donanemab is under scrutiny due to concerns about its effectiveness and safety, according to an investigation. The study highlights multiple patient deaths during trials, design flaws, and the financial ties of panelists who recommended the drug's approval.

Featured Neuroscience Psychology

·August 21, 2024·3 min read

High-Dose Psilocybin Shows Potential as an Antidepressant Treatment

A meta-analysis suggests that high doses of psilocybin may alleviate depressive symptoms similarly to the SSRI drug escitalopram. While the effect size was small, psilocybin outperformed placebo in clinical trials, though study design flaws could have led to overestimated results. The findings indicate that psilocybin, particularly in high doses, may offer a new avenue for treating depression, comparable to existing antidepressants.

Featured Neuroscience

·July 17, 2024·6 min read

Nighttime Exercise Breaks May Extend Sleep by 27 Minutes

A new suggests that three-minute resistance exercise breaks every 30 minutes in the evening can extend sleep duration by an average of 27 minutes. This practice doesn't disrupt sleep quality and could reduce cardiometabolic disease risk. Participants engaged in simple exercises like chair squats and calf raises. Further research is needed to confirm these findings in real-life settings.

Featured Neuroscience Psychology

·May 2, 2024·7 min read

Psilocybin Effective as Antidepressant

Psilocybin, the psychoactive compound in magic mushrooms, is notably more effective at alleviating depression symptoms than conventional controls. Analyzing seven trials with 436 participants, researchers found a substantial improvement in depression scores following psilocybin treatment compared to placebos or other minor psychedelic doses, showcasing a large effect size.

Featured Neurology Neuroscience Psychology

·April 20, 2024·7 min read

Risks of Antipsychotic Use in Dementia Patients

A new study revealed significant risks associated with antipsychotic use in dementia patients, including increased chances of stroke, heart failure, pneumonia, and other serious conditions. The research analyzed data from 173,910 dementia patients in England, tracking those prescribed antipsychotics post-diagnosis against those who were not.

This shows the outline of a woman and a brain.

Brain Cancer Featured Neurology Neuroscience

·March 28, 2024·4 min read

Prolonged Progestogen Use Linked to Brain Tumor Risk

A new study highlights a significant link between prolonged use of certain progestogen hormone drugs and an increased risk of developing intracranial meningioma, a type of brain tumor. Researchers analyzed data from 18,061 women who underwent surgery for intracranial meningioma, comparing their progestogen use to 90,305 controls.

Featured Neuroscience Psychology

·January 18, 2024·6 min read

OCD Linked to Higher Mortality Risks

A new study highlights a concerning link between obsessive-compulsive disorder (OCD) and an increased risk of death from both natural and unnatural causes. The study, using data from over 60,000 people with OCD, shows an 82% higher overall mortality risk compared to those without the disorder.

Auditory Neuroscience Featured Neuroscience

·January 16, 2024·5 min read

Loud Play, Silent Risk: Video Gaming’s Link to Hearing Loss

A systematic review indicates a potential risk of irreversible hearing loss and tinnitus among video gamers due to high sound levels. The study, encompassing over 50,000 individuals, found that sound levels in gaming often near or exceed safe limits.

Featured Neurology Neuroscience

·December 6, 2023·5 min read

Brain Stimulation Enhances Alzheimer’s Cognitive Function

Transcranial direct current stimulation (tDCS) may enhance cognitive function in Alzheimer’s disease patients. The study involved 140 patients with mild to moderate Alzheimer’s, who received either active or sham tDCS twice daily for up to six weeks.

1 2 3 … 6

BMJ

Autoimmune Disease Doubles Risk of Depression and Anxiety

Low-Calorie Diets May Increase Depression Risk

Cold Sore Virus Linked to Alzheimer’s, Antivirals May Lower Risk

Alzheimer’s Drug Faces Scrutiny Over Safety, Efficacy Concerns

High-Dose Psilocybin Shows Potential as an Antidepressant Treatment

Nighttime Exercise Breaks May Extend Sleep by 27 Minutes

Psilocybin Effective as Antidepressant

Risks of Antipsychotic Use in Dementia Patients

Prolonged Progestogen Use Linked to Brain Tumor Risk

OCD Linked to Higher Mortality Risks

Loud Play, Silent Risk: Video Gaming’s Link to Hearing Loss

Brain Stimulation Enhances Alzheimer’s Cognitive Function

Why Your Baby Cries: It’s Largely Written in Their Genes

Side of Parkinson’s Onset Shapes Cognitive and Emotional Decline

Timing of Prozac Treatment Shapes Lasting Mood, Brain Changes

Emotional Neglect in Childhood Undermines Trust in One’s Own Body

Subscribe